A year in pharma and biotech R&D: Lack of large M&As leads to little change
This article was originally published in Scrip
Executive Summary
No surprises in the top 10, but the number of smaller companies involved in R&D, including a wealth of start-ups, continues on its unrelenting growth trajectory.